Preparing T cells for the long haul
New LJI research could keep cancer-fighting T cells from burning out before the job is done
New LJI research could keep cancer-fighting T cells from burning out before the job is done
New A.P. Giannini Foundation Fellowship opens the door to an in-depth look at SARS-CoV-2 infections
LJI researchers highlight the importance of T cell cross reactivity in stopping severe COVID-19 cases
LJI Postdoctoral Fellow Adrian Enriquez wins funding to study how antibodies fight the deadly Lassa virus.
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
Cancer immunotherapies may have a better chance of working if scientists can reintroduce a missing metabolite
Dawid Zyla explores the world’s hidden patterns
New support from the American Cancer Society fuels research into the primary mutations behind many cancer types
National Cancer Institute support brings cancer researchers together to share key findings